High Outlier
Strength
10 mg/mL
Manufacturer
ViiV Healthcare CompanyNDC
49702020548
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Last Updated
3/23/2016
Active Ingredients
LAMIVUDINEApproval Type
New Drug (NDA)
FDA Application
NDA020596On Market Since
10/4/2010
Pharmacological Classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Reverse Transcriptase Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
ZIAGEN 20 MG/ML SOLUTION
Brand
49702022248•ViiV Healthcare Company
$0.5865
per ML
INTELENCE 100 MG TABLET
Brand
59676057001•Janssen Products LP
$10.9213
per EA
COMBIVIR TABLET
Brand
49702020218•ViiV Healthcare Company
$14.3948
per EA
EMTRIVA 200 MG CAPSULE
Brand
61958060101•Gilead Sciences, Inc.
$17.4370
per EA
INTELENCE 200 MG TABLET
Brand
59676057101•Janssen Products LP
$24.2861
per EA
VIREAD 300 MG TABLET
Brand
61958040101•Gilead Sciences, Inc.
$40.7318
per EA
BARACLUDE 1 MG TABLET
Brand
00003161212•E.R. Squibb & Sons, L.L.C.
$43.9221
per EA
BARACLUDE 0.5 MG TABLET
Brand
00003161112•E.R. Squibb & Sons, L.L.C.
$44.1865
per EA
EDURANT 25 MG TABLET
Brand
59676027801•Janssen Products LP
$48.1197
per EA
VEMLIDY 25 MG TABLET
Brand
61958230101•Gilead Sciences, Inc.
$51.9338
per EA